Revolution Medicines
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $261,592 |
Gross Profit | -3,802 | -205,749 | -188,096 | |
EBITDA | -289,440 | -260,912 | -237,044 | -212,923 |
EBIT | -293,778 | -264,714 | -240,760 | -216,310 |
Net Income | -305,206 | -247,787 | -213,416 | -194,569 |
Net Change In Cash | 0 | 0 | 0 | 261,592 |
Free Cash Flow | -210,660 | -229,207 | -197,701 | -139,512 |
Cash | 217,442 | 402,438 | 333,554 | 543,064 |
Basic Shares | 189,231 | 188,145 | 188,146 | 167,737 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $11,580 | $35,380 | $29,390 |
Gross Profit | -592,225 | 11,580 | 35,380 | 29,390 |
EBITDA | -677,700 | -477,876 | -248,623 | -179,747 |
EBIT | -689,524 | -487,185 | -258,279 | -187,079 |
Net Income | -600,093 | -436,367 | -248,705 | -187,091 |
Net Change In Cash | 0 | 11,580 | 35,380 | 29,390 |
Cost of Revenue | 4,882 | |||
Free Cash Flow | -567,744 | -358,301 | -235,217 | -153,708 |
Cash | 543,064 | 696,148 | 161,412 | 108,497 |
Basic Shares | 167,737 | 113,149 | 80,626 | 72,806 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$1.61 |
2025-06-30 | -$1.31 |
2025-03-31 | -$1.13 |
